Doug Long on the State of U.S. Healthcare, Pharmacy Deserts and "Pretty Anemic" Number of Drug Launches | PBMI 2024
The IQVIA vice president and frequent speaker at pharmaceutical and managed care meetings shares some insights after he delivered the keynote talk at 2024 PBMI Annual National Conference held last week in Orlando, Florida. Long, a well-known figure in managed care circles, announced at the PBMI meeting that he is retiring in 2025.
Doug Long, vice president of industry relations at IQVIA, a frequent speaker at the PBMI Annual National Confernece and other pharmaceutical and managed care meetings, discussed what he sees as the fragile state of U.S. healthcare, pharmacy "deserts" and the relatively small number of new drug launches so far in this year.
Long sees the U.S. healthcare as being in a precarious position because of the number of retiring doctors, declining enrollment in pharmacy schools after years of increaes and cyberattacks such as the Change Healthcare attack earlier this year.
Long was interviewed by Managed Healthcare Executive last week after he gave the keynote talk at the 2024 Pharmacy Benefit Management Institute (PBMI) Annual National Conference in Orlando, Florida. He announced that he is retiring in May 2025.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
